title: Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
authors.forename: A
authors.initials: A
authors.lastname: Ramos
authors.forename: I
authors.initials: I
authors.lastname: Cruz
authors.forename: E
authors.initials: E
authors.lastname: Muñez
authors.forename: C
authors.initials: C
authors.lastname: Salas
authors.forename: A
authors.initials: A
authors.lastname: Fernández
authors.forename: T
authors.initials: T
authors.lastname: Alvarez-Espejo
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D018314:Leishmania infantum / Q000302:isolation & purification*; D016773:Leishmaniasis, Cutaneous / Q000150:complications* / Q000188:drug therapy / Q000469:parasitology; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy; D014605:Uveitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D019380:Anti-HIV Agents; D000981:Antiprotozoal Agents; D000666:Amphotericin B